31 March 2026 : Original article
Retrospective Analysis of Risk Factors and Surgical Outcomes in Liver Transplant Recipients
Jamilya SaparbayDOI: 10.12659/AOT.951224
Ann Transplant 2026; 31:e951224
Table 2 Surgical aspects.
| Variables | Mean (StDev) | Range | N (%) |
|---|---|---|---|
| 544 (140.5) | 305–977 | 113 (100) | |
| 2499 (2232) | 300–1500 | ||
| CIT (min) | 170.4 (141.7) | 22–678 | 113 (100) |
| WIT (min) | 46.1 (14.9) | 20–95 | 113 (100) |
| TIT (min) | 217 (145) | 60–719 | 113 (100) |
| 11 (9.73) | |||
| SV/SVIII tributaries | 45 (40.54) | ||
| SV | 7 (6.31) | ||
| S8 | 4 (3.60) | ||
| IRHV | 2 (1.80) | ||
| Without reconstruction | 53 (46.75) | ||
| Single | 84 (74.34) | ||
| Double | 26 (23.01) | ||
| Triple | 3 (2.65) | ||
| DDA | 97 (85.84) | ||
| HJ | 14 (12.39) | ||
| Mixed DDA+HJ | 1 (0.88) | ||
| Mixed DDA+cholangiostoma | 1 (0.88) | ||
| EBD yes | 34 (30) | ||
| EBD no | 79 (70) | ||
| DDA single to 1 | 55 (48.7) | ||
| DDA double to 1 | 10 (8.9) | ||
| DDA triple to 1 | 1 (0.9) | ||
| DDA double to 1 + single to 1 (unmixed) | 1 (0.9) | ||
| DDA double to 2 | 5 (4.4) | ||
| HJ double to 1 | 14 (12.4) | ||
| HJ double to 2 | 1 (0.9) | ||
| DDA single to 1 + HJ single to 1 (mixed) | 1 (0.9) | ||
| DDA single to 1 + cholangiostoma | 1 (0.9) | ||
| Not specified or no data | 24 (21.1) | ||
| 1.2 (0.62) | 0.6–2.9 | 113 (100) | |
| LDLT | 88 (77.9) | ||
| DDLT | 25 (22.1) | ||
| 35.6 (16.9) | 3–88 | 113 (100) | |
| 12 (10.4) | 3–81 | 113 (100) | |
| CIT – cold ischemic time; WIT – warm ischemic time; TIT – total ischemic time; HV – hepatic vein; SV – segment V; IRHV – inferior right hepatic vein; BD – bile duct; DDA – duct-to-duct anastomosis; HJ – hepaticojejunostomy; EBD – external bile duct stenting; BDA – bile duct anastomosis; GRWR – graft-recipient weight ratio; LDLT – living donor liver transplantation; DDLT – deceased donor liver transplantation; ICU – intensive care unit. | |||






